Global Wearable Medical Devices Market is Predicted to Reach USD 185 Billion by 2032 | DelveInsight
The global wearable medical devices market is experiencing rapid growth, driven by the increasing burden of chronic diseases, the adoption of remote patient monitoring, and swift technological progress. Equipped with compact sensors, AI-powered analytics, and 5G connectivity, these devices are transitioning from simple fitness trackers to vital healthcare tools that enable proactive and connected care.
New York, USA, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Global Wearable Medical Devices Market is Predicted to Reach USD 185 Billion by 2032 | DelveInsight
The global wearable medical devices market is experiencing rapid growth, driven by the increasing burden of chronic diseases, the adoption of remote patient monitoring, and swift technological progress. Equipped with compact sensors, AI-powered analytics, and 5G connectivity, these devices are transitioning from simple fitness trackers to vital healthcare tools that enable proactive and connected care.
DelveInsight’s Wearable Medical Devices Market Insights report provides the current and forecast market analysis, individual leading wearable medical devices companies’ market shares, challenges, wearable medical devices market drivers, barriers, trends, and key market wearable medical devices companies in the market.
Wearable Medical Devices Market Summary
- The global wearable medical devices market is expected to increase from USD 43 billion in 2024 to USD 185 billion by 2032, reflecting strong and sustained growth.
- The global wearable medical devices market is expected to grow at a CAGR of ~20% during the forecast period from 2025 to 2032.
- The leading companies working in the wearable medical devices market include Apple Inc., Alphabet Inc., Samsung Electronics Co., Ltd., Garmin Ltd., Koninklijke Philips N.V., Medtronic, Abbott Laboratories, Dexcom, Inc., Boston Scientific Corporation, OMRON Corporation, ResMed, Becton, Dickinson and Company, iRhythm Technologies, Inc., Withings, Vital Connect, Inc., Masimo Corporation, Insulet Corporation, Zoll Medical Corporation, Biotricity Inc., Nuvo Group, Ypsomed, and others.
- Among all the regions, North America is anticipated to register the fastest growth in the wearable medical devices market during the forecast period.
- In the product type segment of the wearable medical devices market, the diagnostic & monitoring devices category accounted for the largest market share in 2024.
To read more about the latest highlights related to the wearable medical devices market, get a snapshot of the key highlights entailed in the Global Wearable Medical Devices Market Forecast Report
Key Factors Contributing to the Rise in Growth of the Wearable Medical Devices Market
Increasing Prevalence of Chronic Diseases
Rising cases of cardiovascular disorders, diabetes, respiratory conditions, and other chronic illnesses are driving demand for continuous monitoring solutions, where wearable devices play a vital role.
Shift Toward Preventive and Personalized Healthcare
Consumers and healthcare providers are increasingly prioritizing preventive care and personalized health management, where wearables offer real-time data and actionable insights.
Technological Advancements
Improvements in sensor technologies, miniaturization, battery life, wireless connectivity, and integration with AI/ML are enhancing device accuracy, usability, and appeal.
Rising Health Awareness and Fitness Trends
Consumers are more health-conscious, driving adoption of fitness trackers, smartwatches, and wearable biosensors that bridge the gap between lifestyle devices and medical-grade equipment.
Integration with Telehealth and Remote Patient Monitoring
The expansion of telemedicine, especially post-COVID-19, has accelerated the demand for connected devices that enable remote patient monitoring and reduce hospital visits.
Regulatory Approvals and Expanding Clinical Applications
Increasing FDA and CE clearances for medical-grade wearables (e.g., ECG, glucose monitoring, arrhythmia detection) are broadening clinical adoption and trust in these devices.
Get a sneak peek at the wearable medical devices market dynamics @ Wearable Medical Devices Market Trends
Regional Wearable Medical Devices Market Insights
In 2024, North America, driven primarily by the U.S., commanded nearly 43% of the global wearable medical devices market. This dominance is supported by robust healthcare infrastructure, high healthcare spending per capita, and a strong innovation ecosystem. Growth is being propelled by the dual adoption of clinical-grade devices in hospitals and consumer-focused wearables, many of which are now gaining FDA approvals for medical use, increasingly bridging consumer health with clinical care. The U.S. continues to serve as a hub for technological advancements and reimbursement-backed uptake of remote monitoring solutions.
Europe is establishing itself as a significant growth region for wearable medical devices, supported by both mature healthcare systems and the expanding use of home healthcare solutions. Market expansion is driven by the region’s aging demographics, rising prevalence of chronic illnesses, and government initiatives in digital health, including Germany’s DiGA framework and the EU’s European Health Data Space (EHDS) project.
The Asia-Pacific region is anticipated to register the fastest expansion, with a striking CAGR of 24.7%. Growth here is fueled by its large population base, increasing middle-class healthcare expenditure, and the highest global prevalence of diabetes and hypertension. Governments in China, India, Japan, and South Korea are prioritizing digital health development, strengthening telemedicine networks, and encouraging local manufacturing of wearables, which is driving down costs and accelerating adoption. Widespread smartphone usage and affordable data connectivity further support mHealth integration, while regional startups and tech giants are rapidly innovating in AI-powered diagnostics and connected healthcare platforms. Consequently, APAC is emerging not only as a key growth engine but also as a potential trendsetter in shaping cost-effective, scalable, and technology-driven healthcare delivery.
To know more about why North America is leading the market growth in the wearable medical devices market, get a snapshot of the Wearable Medical Devices Market Outlook
Recent Developmental Activities in the Wearable Medical Devices Market
- In May 2025, Masimo Corporation received FDA 510(k) clearance for its Masimo W1 watch. This approval expanded the watch's indications to include continuous and spot-check measurements of heart rate and oxygen saturation (SpO2), making it a viable option for a range of clinical settings.
- In April 2025, WHOOP, Inc. obtained FDA clearance for its WHOOP ECG feature. This clearance validates the feature's ability to provide a single-lead electrocardiogram, enabling it to detect and provide notifications for certain heart rhythm irregularities. This approval represents a significant step for a consumer-grade device moving into a more medical-focused space
- In April 2025, VitalConnect, Inc. received FDA 510(k) clearance for its VitalRhythm biosensor. The approval validates the device's ability to continuously monitor and record an ECG, heart rate, and respiratory rate, enhancing its utility for remote patient monitoring.
Wearable Medical Devices Overview
Wearable medical devices are transforming healthcare by enabling continuous monitoring, real-time data collection, and proactive disease management outside of traditional clinical settings. These devices, which include smartwatches, biosensors, fitness trackers, and implantable wearables, can track vital signs such as heart rate, blood pressure, oxygen saturation, glucose levels, and even sleep patterns. By providing clinicians and patients with actionable health insights, wearable technology supports early diagnosis, personalized treatment, and improved adherence to care plans. The integration of artificial intelligence and wireless connectivity further enhances their utility, making remote patient monitoring and telemedicine more effective.
Wearable Medical Devices Market Report Metrics | Details |
Coverage | Global |
Study Period | 2022–2032 |
Wearable Medical Devices Market CAGR | ~20% |
Wearable Medical Devices Market Size by 2032 | USD 185 Billion |
Key Wearable Medical Devices Companies | Apple Inc., Alphabet Inc., Samsung Electronics Co., Ltd., Garmin Ltd., Koninklijke Philips N.V., Medtronic, Abbott Laboratories, Dexcom, Inc., Boston Scientific Corporation, OMRON Corporation, ResMed, Becton, Dickinson and Company, iRhythm Technologies, Inc., Withings, Vital Connect, Inc., Masimo Corporation, Insulet Corporation, Zoll Medical Corporation, Biotricity Inc., Nuvo Group, Ypsomed, and others |
Wearable Medical Devices Market Assessment
-
Wearable Medical Devices Market Segmentation
- Wearable Medical Devices Market Segmentation By Product Type: Diagnostic & Monitoring Devices (Vital Sign Monitoring Devices, Sleep Monitoring Devices, Neuromonitoring Devices, Electrocardiographs Fetal and Obstetric Devices, and Others), Therapeutic Devices (Pain Management Devices, Insulin Delivery Devices, Respiratory Therapy Devices, Rehabilation Devices, and Others)
- Wearable Medical Devices Market Segmentation By Device Type: Smartwatches, Wrist Bands, Smart Clothing, Wearable Patches, and Others
- Wearable Medical Devices Market Segmentation By Device Grade: Consumer Grade Wearable Medical Devices, Clinically Grade Wearable Medical Devices
- Wearable Medical Devices Market Segmentation By Application: General Health and Fitness, Remote Patient Monitoring, and Home Healthcare
- Wearable Medical Devices Market Segmentation By Distribution Channel: Offline, Online
- Wearable Medical Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the wearable medical devices market are set to emerge as the trendsetter explore @ Wearable Medical Devices Market Analysis
Table of Contents
1 | Wearable Medical Devices Market Report Introduction |
2 | Wearable Medical Devices Market Executive Summary |
3 | Competitive Landscape |
4 | Regulatory Analysis |
5 | Wearable Medical Devices Market Key Factors Analysis |
6 | Wearable Medical Devices Market Porter’s Five Forces Analysis |
7 | Wearable Medical Devices Market Layout |
8 | Wearable Medical Devices Market Company and Product Profiles |
9 | KOL Views |
10 | Project Approach |
11 | About DelveInsight |
12 | Disclaimer & Contact Us |
Interested in knowing the wearable medical devices market by 2032? Click to get a snapshot of the Wearable Medical Devices Market Assessment
Related Reports
Smart Medical Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key smart medical devices companies, including Sonova., Abbott., Samsung Electronics Co., Ltd., Medtronic Plc., CeQur Simplicity, DEXCOM, INC., Enable Injections, Garmin LTD., Insulet Corporation, Johnson & Johnson Services, Inc, Neurometrix, INC., Omron Healthcare, INC., F. HOFFMAN-LA ROCHE LTD, Sotera Wireless, INC., Vitalconnect, West Pharmaceutical Services, INC., FitBit, Qardio, Inc., Novo Nordisk A/S, Emperra GmbH E-Health Technologies, among others.
Artificial Intelligence in Life Sciences Market
Artificial Intelligence in Life Sciences Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in life sciences companies, including IBM Corporation, Atomwise, Inc., Nuance Communications, Inc., NuMedii, Inc., AiCure LLC, APIXIO, Inc., Insilico Medicine, Inc., Enlitic, Inc., Sensely, Inc., Zebra Medical Vision, among others.
AI in Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in diagnostics companies, including Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, among others.
Vital Sign Monitoring Devices Market
Vital Sign Monitoring Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key vital sign monitoring devices companies, including Masimo, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION., Nonin Medical, Omron, ACCOSON, Advin Health Care, Lepu Medical Technology, TytoCare Ltd., VYAIRE, SCHILLER, SunTech Medical, Inc., Welch Allyn Inc., Medtronic PLC, GENERAL ELECTRIC COMPANY, Contec Medical Systems Limited, Biobeat, Honsun, Rudolf Riester GmbH, Promed Technology, among others.
Insulin Delivery Device Market
Insulin Delivery Device Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key insulin delivery device companies, including Becton, Dickinson and Company, Medtronic, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo, CeQur, EOFLOW CO., LTD, European Pharma Group BV, Roche, Sanofi, Hindustan Syringes & Medical Devices Ltd, Ocean (Hangzhou) Medical Technology Co Ltd, Owen Mumford, SOOIL Developments Co., Ltd, SUNGSHIM MEDICAL CO., LTD, among others.
DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Contact Us Shruti Thakur info@delveinsight.com +14699457679
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
